JP2011508767A5 - - Google Patents

Download PDF

Info

Publication number
JP2011508767A5
JP2011508767A5 JP2010541098A JP2010541098A JP2011508767A5 JP 2011508767 A5 JP2011508767 A5 JP 2011508767A5 JP 2010541098 A JP2010541098 A JP 2010541098A JP 2010541098 A JP2010541098 A JP 2010541098A JP 2011508767 A5 JP2011508767 A5 JP 2011508767A5
Authority
JP
Japan
Prior art keywords
bosentan
solvent
anhydrous
mixture
production method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010541098A
Other languages
English (en)
Japanese (ja)
Other versions
JP5535082B2 (ja
JP2011508767A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2009/000009 external-priority patent/WO2009083739A1/en
Publication of JP2011508767A publication Critical patent/JP2011508767A/ja
Publication of JP2011508767A5 publication Critical patent/JP2011508767A5/ja
Application granted granted Critical
Publication of JP5535082B2 publication Critical patent/JP5535082B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010541098A 2008-01-01 2009-01-02 ボセンタン、その多形形態及びその塩の合成方法 Expired - Fee Related JP5535082B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN12MU2008 2008-01-01
IN12/MUM/2008 2008-01-01
IN836/MUM/2008 2008-04-09
IN836MU2008 2008-04-09
PCT/GB2009/000009 WO2009083739A1 (en) 2008-01-01 2009-01-02 Method of synthesis of bosentan, its polymorphic forms and its salts

Publications (3)

Publication Number Publication Date
JP2011508767A JP2011508767A (ja) 2011-03-17
JP2011508767A5 true JP2011508767A5 (enExample) 2012-02-23
JP5535082B2 JP5535082B2 (ja) 2014-07-02

Family

ID=40424567

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010541098A Expired - Fee Related JP5535082B2 (ja) 2008-01-01 2009-01-02 ボセンタン、その多形形態及びその塩の合成方法

Country Status (9)

Country Link
US (1) US8481730B2 (enExample)
EP (2) EP2248805A3 (enExample)
JP (1) JP5535082B2 (enExample)
KR (1) KR20100113542A (enExample)
AU (1) AU2009203174B2 (enExample)
CA (1) CA2711043A1 (enExample)
NZ (1) NZ586900A (enExample)
WO (1) WO2009083739A1 (enExample)
ZA (1) ZA201005014B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004287875B2 (en) 2003-11-05 2011-06-02 Bausch + Lomb Ireland Limited Modulators of cellular adhesion
CA2711043A1 (en) 2008-01-01 2009-07-09 Cipla Limited Method of synthesis of bosentan, its polymorphic forms and its salts
US8716477B2 (en) 2009-11-12 2014-05-06 Ranbaxy Laboratories Limited Crystalline forms of bosentan salts and processes for their preparation
JP5356323B2 (ja) * 2010-07-01 2013-12-04 富士化学工業株式会社 新規な非晶質ボセンタン及びその製造方法
WO2012002547A1 (ja) * 2010-07-02 2012-01-05 富士化学工業株式会社 ボセンタン固体分散体
JP5850576B2 (ja) * 2010-07-06 2016-02-03 富士化学工業株式会社 ボセンタン固体分散体
US20130245259A1 (en) 2012-03-16 2013-09-19 Natco Pharma Limited Process for the preparation of bosentan monohydrate
ITMI20120701A1 (it) 2012-04-27 2013-10-28 Dipharma Francis Srl Procedimento per la purificazione di un composto benzensolfonammidico
EP4406950A3 (en) 2012-07-25 2025-04-23 Bausch + Lomb Ireland Limited Lfa-1 inhibitor and polymorph thereof
EP2890694A4 (en) 2012-08-31 2015-12-30 Rao Davuluri Ramamohan 4-TERT-BUTYL-N- [6- (2-HYDROXYETHOXY) -5- (2-METHOXYPHENOXY) -2 (2-PYRIMIDINYL) -PYRIMIDIN-4-YL) -BENZENESULFONAMIDE SODIUM
KR102004422B1 (ko) 2012-12-20 2019-07-26 제일약품주식회사 보센탄 일수화물의 제조방법, 이에 사용되는 신규 중간체 및 이의 제조방법
EP2958914B1 (en) 2013-02-21 2020-07-15 Adverio Pharma GmbH Forms of methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate
KR102259824B1 (ko) * 2018-07-24 2021-06-02 주식회사 마더스제약 보센탄을 함유한 약학 제제
US20250144095A1 (en) * 2022-02-03 2025-05-08 The Johns Hopkins University Compositions and methods for treatment of connective tissue disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2086544C1 (ru) * 1991-06-13 1997-08-10 Хоффманн-Ля Рош АГ Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
US6136971A (en) 1998-07-17 2000-10-24 Roche Colorado Corporation Preparation of sulfonamides
MXPA02006660A (es) * 2000-01-07 2002-12-13 Transform Pharmaceuticals Inc Formacion, identificacion y analisis de diversas formas solidas de alto rendimiento.
WO2001055120A1 (en) 2000-01-25 2001-08-02 F. Hoffmann-La Roche Ag Preparation of sulfonamides
US8288401B2 (en) * 2007-05-08 2012-10-16 Generics [Uk] Limited Polymorphic forms
AU2008272685B2 (en) * 2007-06-29 2013-04-18 Generics [Uk] Limited Process for introduction of hydroxyethoxy side chain in bosentan
EP2205591A1 (en) 2007-10-11 2010-07-14 Actavis Group PTC EHF Novel polymorphs of bosentan
JP2011500780A (ja) * 2007-10-24 2011-01-06 ジェネリクス・(ユーケー)・リミテッド 新規結晶形
CA2711043A1 (en) 2008-01-01 2009-07-09 Cipla Limited Method of synthesis of bosentan, its polymorphic forms and its salts
WO2009093127A2 (en) * 2008-01-24 2009-07-30 Actavis Group Ptc Ehf Substantially pure and a stable crystalline form of bosentan
EP2294056A1 (en) * 2008-05-23 2011-03-16 Synthon B.V. Bosentan salts

Similar Documents

Publication Publication Date Title
JP2011508767A5 (enExample)
JP5535082B2 (ja) ボセンタン、その多形形態及びその塩の合成方法
US20140031554A1 (en) Process for preparing racemic nicotine
WO2016045480A1 (zh) 一种奥贝胆酸的制备方法
WO2010091877A2 (en) Process for producing ambrisentan
JP5584709B2 (ja) 5−(2−{[6−(2,2−ジフルオロ−2−フェニルエトキシ)ヘキシル]アミノ}−1−ヒドロキシエチル)−8−ヒドロキシキノリン−2(1h)−オンの製造方法
CN111303051A (zh) 制5-(3,6-二氢-2,6-二氧-4-三氟甲基-1(2h)-嘧啶基)苯硫酚方法
JP2004051592A (ja) 5−(2’−ピリジル)−2−ピリドン誘導体の製造方法
CA2470560C (en) A process for producing phenserine and its analog
CN107879992B (zh) 一种(1-甲基-1h-[1,2,4]三唑-3-基)-甲醇的制备方法
KR20100118747A (ko) 사포그릴레이트 염산염의 개선된 제조방법
JP5301676B2 (ja) (3s,4s)−4−((r)−2−(ベンジルオキシ)トリデシル)−3−ヘキシル−2−オキセタノンの製造方法及びそれに用いられる新規な中間体
JP6248202B2 (ja) シロドシン及びその中間体の製造方法
US9321712B2 (en) Process for the preparation of ospemifene
CN107286070A (zh) (r)‑2‑(2,5‑二氟苯基)吡咯烷的合成方法及中间体
WO2018010651A1 (zh) 一种奥贝胆酸及其中间体的制备方法
CN109942446A (zh) 一种普瑞巴林的制备方法
WO2012056468A1 (en) A process for the preparation of bosentan
US20070249839A1 (en) Process for the Preparation of Losartan Potassium Form I
CN111960989B (zh) 一种4-溴咔唑制备方法
CN102020600B (zh) 一种吲哚-2-羧酸的合成方法
US20110166351A1 (en) Method for preparing 5-[2-(methylthio)ethoxy]pyrimidine-2-amine
CN118930594A (zh) 合成脱氧胸苷的方法
CN103965130B (zh) 一种帕立骨化醇中间体的制备方法
CN102516156A (zh) 一种2-((1-苄基-4-哌啶基)-羟基-甲基)-5,6-二甲氧基-1-茚酮的合成方法